Answers are grounded in this paper and cite their sources.
Background: Two novel malaria vaccines, RTS,S and R21, mark a significant step forward in malaria research, but eradication demands vaccines with higher efficacy. Recent trials using late-arresting genetically attenuated parasites (LA-GAP) highlight their effectiveness as next-generation vaccines, likely through CD8+ T-cell activation targeting late liver-stage parasites. However, the distribution of LA-GAP-activated T cells in different organs that culminate towards high-level protection in the liver remains unclear. Methods: This study aimed to map immune responses in the livers and lungs of mice immunized with LA-GAP, shedding light on the role of different organs in priming T-cell responses towards immunity. Results: Particularly in the lungs we found an impressive increase of CD8+, double negative T cells (5%), γδ (2.5%), effector memory CD8+ T cells (46%), and tissue resident memory CD8+ T cells (3%). These lung T cells are highly activated (expressing CD11c, Ki67, KLRG1) and exhibited 4-fold higher Granzyme A expression and significant TNF+ cell increases as compared to their liver counterparts (10.2% vs 2.6%). These differences start already at the early 2-day timepoint at which time the lungs show an impressive 10.2% increase in TNF+ CD8+ T cells, whereas the liver shows a more modest increase of 2.6% of these cells. Conclusion: These findings highlight the lungs as a crucial site for immune priming and T-cell activation, underscoring the need for further investigation of organ-specific responses to fully understand the potential of LA-GAP immunization as a powerful strategy in the fight against malaria.
No takes yet. Share an insight, caveat, or question.
Schuijlenburg et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: